Mitochondrial DNA variant discovery and evaluation in human Cardiomyopathies through next-generation sequencing.
Mutations in mitochondrial DNA (mtDNA) may cause maternally-inherited cardiomyopathy and heart failure. In homoplasmy all mtDNA copies contain the mutation. In heteroplasmy there is a mixture of normal and mutant copies of mtDNA. The clinical phenotype of an affected individual depends on the type of genetic defect and the ratios of mutant and normal mtDNA in affected tissues. We aimed at determining the sensitivity of next-generation sequencing compared to Sanger sequencing for mutation detection in patients with mitochondrial cardiomyopathy. We studied 18 patients with mitochondrial cardiomyopathy and two with suspected mitochondrial disease. We "shotgun" sequenced PCR-amplified mtDNA and multiplexed using a single run on Roche's 454 Genome Sequencer. By mapping to the reference sequence, we obtained 1,300x average coverage per case and identified high-confidence variants. By comparing these to >400 mtDNA substitution variants detected by Sanger, we found 98% concordance in variant detection. Simulation studies showed that >95% of the homoplasmic variants were detected at a minimum sequence coverage of 20x while heteroplasmic variants required >200x coverage. Several Sanger "misses" were detected by 454 sequencing. These included the novel heteroplasmic 7501T>C in tRNA serine 1 in a patient with sudden cardiac death. These results support a potential role of next-generation sequencing in the discovery of novel mtDNA variants with heteroplasmy below the level reliably detected with Sanger sequencing. We hope that this will assist in the identification of mtDNA mutations and key genetic determinants for cardiomyopathy and mitochondrial disease.
Zaragoza
Michael V
MV
Genetics & Metabolism Division, Pediatrics Department and Center for Mitochondrial and Molecular Medicine and Genetics, University of California Irvine, Irvine, California, United States of America. mzaragoz@uci.edu
Fass
Joseph
J
Diegoli
Marta
M
Lin
Dawei
D
Arbustini
Eloisa
E
D001483:Base Sequence; D009202:Cardiomyopathies / Q000235:genetics*; D019295:Computational Biology; D004272:DNA, Mitochondrial / Q000235:genetics*; D005260:Female; D014644:Genetic Variation; D006801:Humans; D008297:Male; D028361:Mitochondrial Diseases / Q000235:genetics; D009154:Mutation; D017422:Sequence Analysis, DNA / Q000379:methods*
D004272:DNA, Mitochondrial
Nat Protoc. 2007;2(10):2339-44
17947975
Nat Genet. 2008 Feb;40(2):249-54
18223651
Nat Genet. 2007 Mar;39(3):386-90
17293866
Heart. 1998 Dec;80(6):548-58
10065021
Genet Med. 2009 Feb;11(2):118-26
19265752
Clin Chem. 2009 Apr;55(4):641-58
19246620
Hum Mutat. 2009 Feb;30(2):E386-94
18853457
Nature. 2005 Sep 15;437(7057):376-80
16056220
Proc Natl Acad Sci U S A. 1977 Dec;74(12):5463-7
271968
RNA Biol. 2007 Jan-Mar;4(1):38-66
17617745
Int J Legal Med. 2007 May;121(3):207-13
16645851
Mol Pathol. 2001 Oct;54(5):351-3
11577179
Hum Mutat. 2009 Jan;30(1):1-6
18566966
Nucleic Acids Res. 2007;35(15):e97
17670798
Nature. 2010 Mar 25;464(7288):610-4
20200521
Science. 2008 Feb 15;319(5865):958-62
18276892
Biotechniques. 2010 Apr;48(4):287-96
20569205
Nature. 1981 Apr 9;290(5806):457-65
7219534
BMC Genomics. 2008 Oct 08;9:464
18842124
Genome Biol. 2007;8(7):R143
17659080
Am J Hum Genet. 2009 May;84(5):628-40
19426953
Genome Biol. 2009;10(3):R32
19327155
Nature. 2008 Nov 6;456(7218):53-9
18987734
Genome Med. 2009 Oct 23;1(10):100
19852779
Annu Rev Biochem. 2007;76:781-821
17506638
Biochim Biophys Acta. 2009 Dec;1792(12):1097-102
19303927
Nat Protoc. 2008;3(2):267-78
18274529
Nat Med. 2006 Jul;12(7):852-5
16799556
BMC Plant Biol. 2006 Aug 25;6:17
16934154
Nat Genet. 1999 Oct;23(2):147
10508508
Nucleic Acids Res. 2010 Jan;38(2):522-33
19892826
Genomics. 2005 Oct;86(4):446-61
16024219
Proc Natl Acad Sci U S A. 1980 Nov;77(11):6715-9
6256757
J Pathol. 2010 Jan;220(2):297-306
19927313